摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

9-<2',3'-Dideoxy-3'-C-(hydroxymethyl)-D-erythro-pentofuranosyl>adenine

中文名称
——
中文别名
——
英文名称
9-<2',3'-Dideoxy-3'-C-(hydroxymethyl)-D-erythro-pentofuranosyl>adenine
英文别名
[(2S,3R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-yl]methanol;[(2S,3R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]methanol
9-<2',3'-Dideoxy-3'-C-(hydroxymethyl)-D-erythro-pentofuranosyl>adenine化学式
CAS
——
化学式
C11H15N5O3
mdl
——
分子量
265.272
InChiKey
ROKFTZONUGKALY-GCJDJSOWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1
  • 重原子数:
    19
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    119
  • 氢给体数:
    3
  • 氢受体数:
    7

反应信息

  • 作为产物:
    描述:
    1-N-(6-Chloropurin-9-yl) 5-O-benzoyl-3-C-<(benzoyloxy)methyl>-2,3-dideoxy-erythro-furanoside 在 作用下, 以 甲醇 为溶剂, 反应 20.0h, 生成 9-<2',3'-Dideoxy-3'-C-(hydroxymethyl)-D-erythro-pentofuranosyl>adenine
    参考文献:
    名称:
    A Novel Approach toward the Synthesis of Chiral 2,3-Dideoxy Nucleosides and Their Carbocyclic Analogs
    摘要:
    Photochemical ring-expansion of chiral 2(S),3(R)-bis[(benzoyloxy) methyl] cyclobutanone (3) in the presence of alcohols and acidic N-H functional groups gives anomeric mixtures of acetals and N-amino acetals, respectively, with retention of stereochemistry of the ring substituents. In the presence of purine and 6-chloropurine the corresponding protected nucleosides are-obtained. The photoadduct with 6-chloropurine is converted to the known medicinally active deprotected adenine nucleoside with methanolic ammonia. One-carbon homologation of ketone 3 with diazomethane produces the corresponding optically pure cyclopentanone 8 with retention of stereochemistry. This ketone is converted to the optically pure cyclopentylamine 10 in two steps. Racemic amine 10 has been used as a key intermediate in the preparation of carbocyclic nucleosides.
    DOI:
    10.1021/jo00087a029
点击查看最新优质反应信息